Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.

Inamdar AA, Goy A, Ayoub NM, Attia C, Oton L, Taruvai V, Costales M, Lin YT, Pecora A, Suh KS.

Oncotarget. 2016 Jul 26;7(30):48692-48731. doi: 10.18632/oncotarget.8961. Review.

2.

BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.

Pettirossi V, Santi A, Imperi E, Russo G, Pucciarini A, Bigerna B, Schiavoni G, Fortini E, Spanhol-Rosseto A, Sportoletti P, Mannucci R, Martelli MP, Klein-Hitpass L, Falini B, Tiacci E.

Blood. 2015 Feb 19;125(8):1207-16. doi: 10.1182/blood-2014-10-603100. Epub 2014 Dec 5.

3.

Protective effect of indomethacin in renal ischemia-reperfusion injury in mice.

Zhu SH, Zhou LJ, Jiang H, Chen RJ, Lin C, Feng S, Jin J, Chen JH, Wu JY.

J Zhejiang Univ Sci B. 2014 Aug;15(8):735-42. doi: 10.1631/jzus.B1300196.

4.

Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.

Zare H, Bashashati A, Kridel R, Aghaeepour N, Haffari G, Connors JM, Gascoyne RD, Gupta A, Brinkman RR, Weng AP.

Am J Clin Pathol. 2012 Jan;137(1):75-85. doi: 10.1309/AJCPMMLQ67YOMGEW.

5.

BRAF mutations in hairy-cell leukemia.

Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B.

N Engl J Med. 2011 Jun 16;364(24):2305-15. doi: 10.1056/NEJMoa1014209. Epub 2011 Jun 11.

6.

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.

Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadström T, Borrebaeck C.

Haematologica. 2009 Nov;94(11):1563-8. doi: 10.3324/haematol.2009.008474.

7.

A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas.

Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, Dalla-Favera R, Califano A.

Mol Syst Biol. 2008;4:169. doi: 10.1038/msb.2008.2. Epub 2008 Feb 12.

8.

Fluorescence PCR quantification of cyclin D1 expression.

Elenitoba-Johnson KS, Bohling SD, Jenson SD, Lin Z, Monnin KA, Lim MS.

J Mol Diagn. 2002 May;4(2):90-6.

Supplemental Content

Support Center